Intrinsiqs

Is Atara Biotherapeutics, Inc. overvalued?

Atara Biotherapeutics, Inc. (ATRA) — key valuation metrics and fundamentals.

No verdict
Price
$7.70
Fair value
—
Current P/E
—
Normal P/E
—
Market cap
$78.5M
Dividend yield
0.0%
Return on equity
38.8%
Sector
Healthcare

See the full interactive analysis →

Fair value compares ATRA's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.